Treatment Variation in Older Adults With Differentiated Thyroid Cancer

被引:4
|
作者
Sutton, Whitney [1 ]
Canner, Joseph K. [1 ]
Segev, Dorry L. [1 ]
Zeiger, Martha A. [2 ]
Mathur, Aarti [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Surg, 600 North Wolfe St,Blalock 606, Baltimore, MD 21287 USA
[2] NCI, Dept Surg Oncol, NIH, Bethesda, MD 20892 USA
关键词
Thyroid cancer; Aging; Thyroidectomy; Disease-specific mortality; ASSOCIATION MANAGEMENT GUIDELINES; UNITED-STATES; YOUNG AGE; PAPILLARY; SURVIVAL; PREDICTORS; PROGNOSIS; MORTALITY; NODULES; PATIENT;
D O I
10.1016/j.jss.2020.04.013
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The growth of the aging population coupled with the increasing incidence of thyroid cancer warrants a better understanding of thyroid cancer in older adults. We aimed to investigate the variation of treatment patterns and determine if the extent of surgery is associated with disease-specific mortality in older adults with differentiated thyroid cancer (DTC). Methods: We performed a population-based study using the Surveillance, Epidemiology, and End Results 18 program to examine patients diagnosed with DTC between 2004 and 2015. Patients were stratified by age: younger adults (aged 18-54 y), middle adults (aged 5564 y), older adults (aged 65-79 y), and super elderly (aged >= 80 y). Disease-specific mortality was estimated using Kaplan-Meier curves and compared using the log-rank test. Multi variable Cox regression was used to assess associations between clinicopathologic characteristics and treatment patterns on disease-specific mortality. Results: Of 117,098 patients with DTC, 72,368 were younger adults, 23,726 middle adults, 18,119 older adults, and 2885 were super elderly. In patients with DTC, compared with younger adults, fewer middle, older, and super elderly adults underwent any surgery (99.0%, 98.4%, 97.4%, and 89.1%, respectively; P < 0.001) or received radioactive iodine (RAI; 48.7%, 42.5%, 39.7%, and 30.7%, respectively; P < 0.001). Furthermore, middle, older, and super elderly adults had higher risk of mortality from DTC (hazard ratio [HR]: 4.0, 95% confidence interval [CI]: 3.2-4.8, P < 0.001; HR: 7.6, 95% CI: 6.3-9.1, P < 0.001; and HR: 17.2, 95% CI: 13.8-21.3, P < 0.001, respectively). On multivariable Cox regression while adjusting for clinicopathologic confounders, management was a significant prognostic factor (no surgery HR: 3.8, 95% CI: 3.1-4.6, P < 0.001; and RAI HR: 0.7, 95% CI: 0.6-0.8, P < 0.001). Conclusions: In patients with DTC, fewer older adults (>= 65 y) underwent surgery or treatment with RAI, and this was associated with a worse disease-specific survival. Surgical decision-making in the older population is complex, and future prospective studies are needed to assess this age-related treatment variation. (c) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:154 / 164
页数:11
相关论文
共 50 条
  • [1] A Neglected Point: Frailty in Older Adults with Differentiated Thyroid Cancer
    Coskun, Meric
    Cataltepe, Esra
    Varan, Hacer Dogan
    Ceker, Eda
    Bektas, Yasemin
    Kuscu, Yasemin
    Yalcin, Mehmet Muhittin
    Akturk, Mujde
    Toruner, Fusun Balos
    Karakoc, Mehmet Ayhan
    Altinova, Alev Eroglu
    ENDOCRINOLOGY AND METABOLISM, 2024, 39 (06) : 899 - 907
  • [2] Impact of the 2015 American thyroid association guidelines on treatment in older adults with low-risk, differentiated thyroid cancer
    Sutton, Whitney
    Crepeau, Philip K.
    Canner, Joseph K.
    Karzai, Shkala
    Segev, Dorry L.
    Mathur, Aarti
    AMERICAN JOURNAL OF SURGERY, 2022, 224 (01): : 412 - 417
  • [3] The treatment of differentiated thyroid cancer
    Hubold, C.
    Buchmann, I.
    Lehnert, H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (17) : 891 - 895
  • [4] Contemporary considerations in adjuvant radioiodine treatment of adults with differentiated thyroid cancer
    Juweid, Malik E.
    Tulchinsky, Mark
    Mismar, Ayman
    Momani, Munther
    Zayed, Ayman A.
    Al Hawari, Hussam
    Albsoul, Nader
    Mottaghy, Felix M.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (09) : 2345 - 2354
  • [5] Global variation in the pattern of differentiated thyroid cancer
    Woodruff, Stacey L.
    Arowolo, Olukayode A.
    Akute, Olusola O.
    Afolabi, Adefemi O.
    Nwariaku, Fiemu
    AMERICAN JOURNAL OF SURGERY, 2010, 200 (04): : 462 - 466
  • [6] Simulated data-driven hospital selection for surgical treatment of well-differentiated thyroid cancer in older adults
    Finn, Caitlin B.
    Wirtalla, Chris
    Mascuilli, Tory
    Krumeich, Lauren N.
    Wachtel, Heather
    Fraker, Douglas
    Kelz, Rachel R.
    SURGERY, 2023, 173 (01) : 207 - 214
  • [7] Clinicopathological features and treatment outcomes of differentiated thyroid cancer in Saudi children and adults
    AL-Qahtani, Khalid Hussain
    Tunio, Mutahir A.
    Al Asiri, Mushabbab
    Aljohani, Naji J.
    Bayoumi, Yasser
    Riaz, Khalid
    AlShakweer, Wafa
    JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2015, 44
  • [8] “Clinicopathological features and treatment outcomes of differentiated thyroid cancer in Saudi children and adults”
    Khalid Hussain AL-Qahtani
    Mutahir A. Tunio
    Mushabbab Al Asiri
    Naji J. Aljohani
    Yasser Bayoumi
    Khalid Riaz
    Wafa AlShakweer
    Journal of Otolaryngology - Head & Neck Surgery, 44
  • [9] Advancements in the treatment of differentiated thyroid cancer
    Stewart, Latoya A.
    Kuo, Jennifer H.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2021, 12
  • [10] Radioiodine treatment for differentiated thyroid cancer
    Vini, L
    Harmer, C
    CLINICAL ONCOLOGY, 2000, 12 (06) : 365 - 372